We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cyclooxygenase Inhibitors Decrease Antibody Response to Vaccination

By LabMedica International staff writers
Posted on 23 Dec 2009
The effectiveness of vaccination may be significantly diminished if the individual receiving the vaccine has been treated with an inhibitor of cyclooxygenase-1 (COX-1), which also causes a drop in the production of interleukin-17 (IL-17).

The COX enzymes are known modulators of innate immune cell function; however, their contributions to adaptive immunity (antibody production) are relatively unknown. More...
Therefore, investigators at the University of Missouri (Columbia, USA) studied the roles of COX-1 and COX-2 in the humoral immune response to infection with the Lyme disease pathogen Borrelia burgdorferi.

The investigators reported in the November 1, 2009, issue of The Journal of Immunology that in vitro, mouse B cells expressed COX-1 at a constant rate, but upregulated expression of COX-1 and COX-2 as well as their products PGE2, PGF2-alpha, and thromboxane B2, and their receptors following stimulation with B. burgdorferi. In vitro inhibition of COX-1 and/or COX-2 resulted in decreased eicosanoid production and altered antibody production. Importantly, infection of mice lacking COX-1, but not COX-2, activity resulted in a defect in immunoglobulin class switching and a lack of Borrelia-specific IgG production. This defect correlated with decreased IL-6 and IL-17 production, and it could be partially recovered by restoration of IL-6, but fully recovered by IL-17.

Furthermore, sera from COX-1 inhibitor-treated mice were dramatically less effective in killing B. burgdorferi, but borreliacidal activity was restored in COX-1 inhibitor-treated mice administered IL-17. Thus, IL-17 plays a role in antibody production and immunoglobulin class switching in response to infection, and that COX-1 is a critical, previously unrecognized regulator of this response.

"If you are taking aspirin regularly, which many people do for cardiovascular treatment, or acetaminophen for pain and fever and get a flu shot, there is a good chance that you will not have a good antibody response,” said senior author Dr. Charles Brown, associate professor of veterinary pathobiology at the University of Missouri. "These drugs block the enzyme COX-1, which works in tissues throughout the body. We have found that if you block COX-1, you might be decreasing the amount of antibodies your body is producing, and you need high amounts of antibodies to be protected.”

"So far, we have tested this on an animal model and have found that these nonsteroidal drugs do inhibit vaccines, but the next step is to test it on humans,” said Dr. Brown. "If our results show that COX-1 inhibitors affect vaccines, the takeaway might be to not take drugs, such as aspirin, acetaminophen, and ibuprofen for a couple weeks before and after you get a vaccine.”

Related Links:
University of Missouri


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Sepsis Test
SeptiCyte RAPID
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more

Pathology

view channel
Image: Spatial characterization of immune–tumor interactions and treatment response across SCLC and extended phenotype models (Cristian Barrera et al, npj Precision Oncology (2026). DOI: 10.1038/s41698-025-01225-9)

AI Pathology Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.